Navigation Links
Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
Date:7/26/2012

DANBURY, Conn., July 26, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.

"We are gratified to receive this award recognizing our innovations in the development of novel therapies to treat diabetes," said Dr. Errol De Souza, President and CEO of Biodel. "These funds will be focused on applying our proprietary technology for the development of ultra-rapid-acting insulin formulations for the treatment of insulin resistant patients and to assist in the development of effective artificial pancreas therapy."

The two-year grant, totaling $582,473, is intended to fund research to develop Biodel's proprietary ultra-rapid-acting insulin product candidate at high concentrations suited to provide sufficient quantities of insulin in an external artificial pancreas pump device that has a limited volume capacity. Currently, regular insulin at concentrations of 500 units per milliliter is used to treat extremely insulin resistant patients with diabetes. While these formulations are 5-times more concentrated than typical insulin presentations, they have a prolonged duration of action that may be undesirable for use with an artificial pancreas. Concentrated formulations of Biodel's ultra-rapid-acting insulin may be absorbed more rapidly than existing concentrated insulin formulations and may therefore become an important component of an effective step in the development of an artificial pancreas.

This research is supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number R43DK096604. This press release an
'/>"/>

SOURCE Biodel Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
2. Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
3. Biodel Obtains Exclusive License to Aegis Therapeutics Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
4. Biodel Announces $18.5 Million Private Placement
5. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
6. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
7. QBC Diagnostics Awarded GSA Contract
8. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
9. Northwest Bio Awarded $5.5 Million German Government Grant
10. Nonin Medical Awarded Novation Contract for Clinically Proven Pulse Oximeters
11. Elsevier / Gold Standards Kay Morgan Awarded NCPCP Highest Honor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... DRAPER, Utah , Aug. 28, 2015  Today, ... and Prevention,s (CDC) Contact Lens Health Week, 1-800 Contacts ... CDC has found that contact lens wearers who do ... the greatest risk for eye infections. ... cleaning their lenses, but a clean lens case is ...
(Date:8/28/2015)... -- Research and Markets ( ... "Investigation Report on China,s Quetiapine Market, 2010-2019" ... by AstraZeneca plc, quetiapine (under the trade name ... treatment of schizophrenia. Approved by CFDA to treat ... Catalogue of Drugs for the Basic National Medical ...
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by Pharmacia & Upjohn ... agonist which effectively reduces intraocular pressure. As the ... (under the trade name of Xalatan) entered ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2China Quetiapine Market Investigation Report 2010-2019 2China Latanoprost Market Investigation Report 2015-2019 2
... 10, 2007 - According to,The Waismann Method ... respondents seeking treatment for opiate dependency have ... OxyContin, Percocet,and Fentanyl were among the drugs ... who reported a dependency said they suffered ...
... a German biopharmaceutical company specialized in targeted,therapies for ... IIb-study with AP 12009 in high-grade glioma will ... American Society of,Clinical Oncology (ASCO), which will be ... 5th. , In the open-label, randomized dose-finding Phase,IIb-trial ...
Cached Medicine Technology:Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 22007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 22007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 3
(Date:8/31/2015)... ... August 31, 2015 , ... DR. ... Luciana Lagana (aka Dr. Luciana) received a total of three Silver Medal ... Documentary, and Best (Dis)ability Film. Dr. Luciana co-wrote and co-produced this pilot with ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... primary care, is enhancing its existing presence in Tennessee with the opening of ... is the company’s second in Knoxville, sixteenth in Tennessee, and 148th in the ...
(Date:8/31/2015)... Pittsburgh, PA (PRWEB) , ... August 31, 2015 , ... ... that they’ll have a higher body mass index and bigger waist circumference, a 15-year ... , The association did not hold in later years, indicating that young adulthood is ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... With baseball ... play-offs and the World Series will dominate the sports world. Fans desire nothing more ... advance to the final series. For children, especially those who are too young to ...
(Date:8/31/2015)... ... August 31, 2015 , ... Castle Dermatology Institute now welcomes ... Ghasri is a graduate of the University of California, Los Angeles. He graduated summa ... the University of California, Irvine Medical School. As a nationally recognized Regents Scholar, Dr. ...
Breaking Medicine News(10 mins):Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Watching More TV as a Young Adult Predicts Obesity 2Health News:Watching More TV as a Young Adult Predicts Obesity 3Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2
... 13 Quintiles,Transnational Corp. today announced that its ... College of American Pathologists (CAP)., The central ... the first,quarter of 2007. The facility has seen ... capabilities to a growing test menu., "CAP ...
... a press conference hosted by New York,Attorney General Andrew ... probe of 16 national health insurers regarding an alleged,scheme ... The following is,attributable to Nancy H. Nielsen, M.D., Ph.D., ... York Attorney General Andrew,Cuomo calls into question the validity ...
... of Alberta study, analyzing a sample of over 275,000 ... in physical activity, one size does not fit all. ... when deciding how and if a person wants to ... at the University of Alberta. It is clear that ...
... NEW YORK, Feb. 13 Today, more than ... challenges from,all sides. Internally, the pressure to fill ... generics demand new outcomes from,pharmaceutical marketing and sales ... regulatory (e.g. post-approval monitoring),legislative, and patent issues continue ...
... VALLEY, Calif., Feb. 13 Sun Busters(R), the swim,wear ... and providing,the ultimate in sun protection now sports a ... of Recommendation! Sun Busters is proud,to announce that they ... products that have a UPF of 50+. UPF is ...
... Feb. 13 Statistics released by the,Centers for Disease ... American children is affected by autism. In Georgia, these ... that is rising in,prevalence with alarming speed. It is ... Georgia are affected by autism, a disorder of,unknown origin ...
Cached Medicine News:Health News:Quintiles Central Laboratory in India Receives CAP Certification 2Health News:AMA Commends N.Y. Investigation of Health Insurers 2Health News:Study: When it comes to physical activity, one size does not fit all 2Health News:Legislative and Regulatory Outlook - 2009 and Beyond for Pharma, Biotech Players 2Health News:Sun Busters(R) Now Sports The Skin Cancer Foundation's Seal of Recommendation 2Health News:Sun Busters(R) Now Sports The Skin Cancer Foundation's Seal of Recommendation 3Health News:2008 Georgia Walk for Autism Supporters Gather in Atlanta for Kick-Off Dinner 2
... The RoamAlert Integrity system builds ... ECO. All door controllers in the ... computer running a standard Windows® operating ... the use of a personal computer, ...
... The RoamAlert ECO system ... or several doors. Each exit ... controller. When a resident wearing ... door, the door will lock; ...
... uses RFID to gather patient ... departments such as surgical and ... updates of patient location to ... care events have occurred and ...
... Identification (RFID) helps incorporate people and intelligent ... healthcare value chain. The power of RFID ... automate and optimize business activities in support ... pharmaceutical inventories, RFID offers tremendous potential to ...
Medicine Products: